2m 2m 2m 2m 2m 2m 2m
ONKURE THERAP-A (OKUR)
NASDAQ
$3.09-$0.01 (-0.32%)
Price as of Sep 11, 2026 7:30 PM EDT- $125.5MMarket Cap
- 26.53%1-Year Change
- BiotechnologyIndustry
ONKURE THERAP-A (OKUR)
$3.09-$0.01 (-0.32%)
OKUR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.10 | ||
Change | -$0.17 (-5.20%) | ||
Open | $3.31 | ||
High | $3.33 | ||
Low | $2.98 | ||
Previous Close | $3.27 | ||
Volume | 253,647 | ||
30-Day Average Volume | 159,819 | ||
1-Week Change | -13.41% | ||
1-Month Change | -24.21% | ||
1-Year Change | 26.53% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 40.5M | ||
Total Assets | $179.4M | ||
Market Cap | $125.5M | ||
Enterprise Value | -$41.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.6M | ||
Net Income | -$15.3M | ||
Free Cash Flow | -$10.4M | ||
EBIT | -$15.3M | ||
EBITDA | -$15.3M | ||
Net Working Capital | $171.0M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | -26 | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue